nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—Vitamin A—ALDH1A1—kidney cancer	0.00551	0.256	CrCbGaD
Acitretin—Tretinoin—ALDH1A1—kidney cancer	0.00532	0.247	CrCbGaD
Acitretin—RXRA—renal system—kidney cancer	0.00531	0.108	CbGeAlD
Acitretin—Alitretinoin—CRABP1—kidney cancer	0.00523	0.243	CrCbGaD
Acitretin—RBP1—renal system—kidney cancer	0.00515	0.105	CbGeAlD
Acitretin—RXRA—kidney—kidney cancer	0.00513	0.105	CbGeAlD
Acitretin—RBP1—kidney—kidney cancer	0.00498	0.102	CbGeAlD
Acitretin—RBP1—cortex of kidney—kidney cancer	0.00485	0.0989	CbGeAlD
Acitretin—RBP1—gonad—kidney cancer	0.00462	0.0942	CbGeAlD
Acitretin—RBP1—cardiac atrium—kidney cancer	0.00461	0.0941	CbGeAlD
Acitretin—RXRB—cardiac atrium—kidney cancer	0.00392	0.08	CbGeAlD
Acitretin—Tretinoin—CRABP1—kidney cancer	0.00369	0.172	CrCbGaD
Acitretin—RARA—renal system—kidney cancer	0.00366	0.0745	CbGeAlD
Acitretin—RARA—kidney—kidney cancer	0.00353	0.0721	CbGeAlD
Acitretin—RARA—gonad—kidney cancer	0.00328	0.0668	CbGeAlD
Acitretin—Vitamin A—CYP1A1—kidney cancer	0.000649	0.0302	CrCbGaD
Acitretin—Tretinoin—CYP1A1—kidney cancer	0.000627	0.0292	CrCbGaD
Acitretin—Alitretinoin—ABCB1—kidney cancer	0.000473	0.022	CrCbGaD
Acitretin—Rash—Everolimus—kidney cancer	0.000221	0.000352	CcSEcCtD
Acitretin—Dermatitis—Everolimus—kidney cancer	0.000221	0.000351	CcSEcCtD
Acitretin—Headache—Vinblastine—kidney cancer	0.000221	0.000351	CcSEcCtD
Acitretin—Angioedema—Paclitaxel—kidney cancer	0.000221	0.000351	CcSEcCtD
Acitretin—Purpura—Doxorubicin—kidney cancer	0.00022	0.00035	CcSEcCtD
Acitretin—Headache—Everolimus—kidney cancer	0.00022	0.00035	CcSEcCtD
Acitretin—Abdominal pain—Dactinomycin—kidney cancer	0.000219	0.000349	CcSEcCtD
Acitretin—Body temperature increased—Dactinomycin—kidney cancer	0.000219	0.000349	CcSEcCtD
Acitretin—Visual impairment—Capecitabine—kidney cancer	0.000219	0.000349	CcSEcCtD
Acitretin—Asthenia—Sorafenib—kidney cancer	0.000219	0.000348	CcSEcCtD
Acitretin—Malaise—Paclitaxel—kidney cancer	0.000218	0.000346	CcSEcCtD
Acitretin—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000216	0.000344	CcSEcCtD
Acitretin—Hypersensitivity—Sunitinib—kidney cancer	0.000216	0.000343	CcSEcCtD
Acitretin—Decreased appetite—Vincristine—kidney cancer	0.000216	0.000343	CcSEcCtD
Acitretin—Pruritus—Sorafenib—kidney cancer	0.000216	0.000343	CcSEcCtD
Acitretin—Vomiting—Erlotinib—kidney cancer	0.000215	0.000342	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000214	0.000341	CcSEcCtD
Acitretin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000214	0.00034	CcSEcCtD
Acitretin—Fatigue—Vincristine—kidney cancer	0.000214	0.00034	CcSEcCtD
Acitretin—Rash—Erlotinib—kidney cancer	0.000214	0.000339	CcSEcCtD
Acitretin—Dermatitis—Erlotinib—kidney cancer	0.000213	0.000339	CcSEcCtD
Acitretin—Insomnia—Gemcitabine—kidney cancer	0.000213	0.000338	CcSEcCtD
Acitretin—Eye disorder—Capecitabine—kidney cancer	0.000213	0.000338	CcSEcCtD
Acitretin—Headache—Erlotinib—kidney cancer	0.000212	0.000337	CcSEcCtD
Acitretin—Tinnitus—Capecitabine—kidney cancer	0.000212	0.000337	CcSEcCtD
Acitretin—Pain—Vincristine—kidney cancer	0.000212	0.000337	CcSEcCtD
Acitretin—Constipation—Vincristine—kidney cancer	0.000212	0.000337	CcSEcCtD
Acitretin—Osteoarthritis—Doxorubicin—kidney cancer	0.000212	0.000337	CcSEcCtD
Acitretin—Diplopia—Doxorubicin—kidney cancer	0.000212	0.000337	CcSEcCtD
Acitretin—Paraesthesia—Gemcitabine—kidney cancer	0.000211	0.000336	CcSEcCtD
Acitretin—Flushing—Capecitabine—kidney cancer	0.000211	0.000336	CcSEcCtD
Acitretin—Cough—Paclitaxel—kidney cancer	0.000211	0.000335	CcSEcCtD
Acitretin—Asthenia—Sunitinib—kidney cancer	0.00021	0.000334	CcSEcCtD
Acitretin—Nausea—Vinblastine—kidney cancer	0.000209	0.000333	CcSEcCtD
Acitretin—Somnolence—Gemcitabine—kidney cancer	0.000209	0.000332	CcSEcCtD
Acitretin—Migraine—Doxorubicin—kidney cancer	0.000209	0.000332	CcSEcCtD
Acitretin—Nausea—Everolimus—kidney cancer	0.000209	0.000331	CcSEcCtD
Acitretin—Diarrhoea—Sorafenib—kidney cancer	0.000208	0.000331	CcSEcCtD
Acitretin—Pruritus—Sunitinib—kidney cancer	0.000207	0.00033	CcSEcCtD
Acitretin—Angiopathy—Capecitabine—kidney cancer	0.000206	0.000328	CcSEcCtD
Acitretin—Immune system disorder—Capecitabine—kidney cancer	0.000206	0.000327	CcSEcCtD
Acitretin—Arthralgia—Paclitaxel—kidney cancer	0.000205	0.000327	CcSEcCtD
Acitretin—Chest pain—Paclitaxel—kidney cancer	0.000205	0.000327	CcSEcCtD
Acitretin—Myalgia—Paclitaxel—kidney cancer	0.000205	0.000327	CcSEcCtD
Acitretin—Anxiety—Paclitaxel—kidney cancer	0.000205	0.000325	CcSEcCtD
Acitretin—Decreased appetite—Gemcitabine—kidney cancer	0.000205	0.000325	CcSEcCtD
Acitretin—Hypersensitivity—Dactinomycin—kidney cancer	0.000205	0.000325	CcSEcCtD
Acitretin—Chills—Capecitabine—kidney cancer	0.000204	0.000325	CcSEcCtD
Acitretin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000203	0.000323	CcSEcCtD
Acitretin—Discomfort—Paclitaxel—kidney cancer	0.000203	0.000323	CcSEcCtD
Acitretin—Fatigue—Gemcitabine—kidney cancer	0.000203	0.000322	CcSEcCtD
Acitretin—Gastrointestinal pain—Vincristine—kidney cancer	0.000203	0.000322	CcSEcCtD
Acitretin—Dizziness—Sorafenib—kidney cancer	0.000202	0.00032	CcSEcCtD
Acitretin—Pain—Gemcitabine—kidney cancer	0.000201	0.00032	CcSEcCtD
Acitretin—Constipation—Gemcitabine—kidney cancer	0.000201	0.00032	CcSEcCtD
Acitretin—Nausea—Erlotinib—kidney cancer	0.000201	0.00032	CcSEcCtD
Acitretin—Alopecia—Capecitabine—kidney cancer	0.000201	0.00032	CcSEcCtD
Acitretin—Dry mouth—Paclitaxel—kidney cancer	0.000201	0.000319	CcSEcCtD
Acitretin—Diarrhoea—Sunitinib—kidney cancer	0.000201	0.000319	CcSEcCtD
Acitretin—Asthenia—Dactinomycin—kidney cancer	0.000199	0.000317	CcSEcCtD
Acitretin—Blood creatinine increased—Doxorubicin—kidney cancer	0.000199	0.000316	CcSEcCtD
Acitretin—Erythema—Capecitabine—kidney cancer	0.000198	0.000315	CcSEcCtD
Acitretin—Oedema—Paclitaxel—kidney cancer	0.000197	0.000313	CcSEcCtD
Acitretin—Abdominal pain—Vincristine—kidney cancer	0.000196	0.000312	CcSEcCtD
Acitretin—Body temperature increased—Vincristine—kidney cancer	0.000196	0.000312	CcSEcCtD
Acitretin—Liver function test abnormal—Doxorubicin—kidney cancer	0.000196	0.000311	CcSEcCtD
Acitretin—Infection—Paclitaxel—kidney cancer	0.000196	0.000311	CcSEcCtD
Acitretin—Dry skin—Doxorubicin—kidney cancer	0.000194	0.000309	CcSEcCtD
Acitretin—Dysgeusia—Capecitabine—kidney cancer	0.000194	0.000308	CcSEcCtD
Acitretin—Dizziness—Sunitinib—kidney cancer	0.000194	0.000308	CcSEcCtD
Acitretin—Feeling abnormal—Gemcitabine—kidney cancer	0.000194	0.000308	CcSEcCtD
Acitretin—Vomiting—Sorafenib—kidney cancer	0.000194	0.000308	CcSEcCtD
Acitretin—Rash—Sorafenib—kidney cancer	0.000192	0.000305	CcSEcCtD
Acitretin—Dermatitis—Sorafenib—kidney cancer	0.000192	0.000305	CcSEcCtD
Acitretin—Back pain—Capecitabine—kidney cancer	0.000192	0.000305	CcSEcCtD
Acitretin—Skin disorder—Paclitaxel—kidney cancer	0.000191	0.000304	CcSEcCtD
Acitretin—Headache—Sorafenib—kidney cancer	0.000191	0.000303	CcSEcCtD
Acitretin—Muscle spasms—Capecitabine—kidney cancer	0.00019	0.000303	CcSEcCtD
Acitretin—Hyperhidrosis—Paclitaxel—kidney cancer	0.00019	0.000303	CcSEcCtD
Acitretin—Diarrhoea—Dactinomycin—kidney cancer	0.00019	0.000302	CcSEcCtD
Acitretin—Anorexia—Paclitaxel—kidney cancer	0.000188	0.000298	CcSEcCtD
Acitretin—Gastritis—Doxorubicin—kidney cancer	0.000188	0.000298	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—kidney cancer	0.000187	0.000297	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000187	0.000297	CcSEcCtD
Acitretin—Vision blurred—Capecitabine—kidney cancer	0.000187	0.000297	CcSEcCtD
Acitretin—Vomiting—Sunitinib—kidney cancer	0.000186	0.000296	CcSEcCtD
Acitretin—Body temperature increased—Gemcitabine—kidney cancer	0.000186	0.000296	CcSEcCtD
Acitretin—Rash—Sunitinib—kidney cancer	0.000185	0.000294	CcSEcCtD
Acitretin—Dermatitis—Sunitinib—kidney cancer	0.000185	0.000294	CcSEcCtD
Acitretin—Ill-defined disorder—Capecitabine—kidney cancer	0.000184	0.000292	CcSEcCtD
Acitretin—Headache—Sunitinib—kidney cancer	0.000184	0.000292	CcSEcCtD
Acitretin—Hypersensitivity—Vincristine—kidney cancer	0.000183	0.00029	CcSEcCtD
Acitretin—Nausea—Sorafenib—kidney cancer	0.000181	0.000288	CcSEcCtD
Acitretin—Pancreatitis—Doxorubicin—kidney cancer	0.00018	0.000286	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000179	0.000285	CcSEcCtD
Acitretin—Malaise—Capecitabine—kidney cancer	0.000179	0.000284	CcSEcCtD
Acitretin—Insomnia—Paclitaxel—kidney cancer	0.000178	0.000283	CcSEcCtD
Acitretin—Asthenia—Vincristine—kidney cancer	0.000178	0.000283	CcSEcCtD
Acitretin—Paraesthesia—Paclitaxel—kidney cancer	0.000177	0.000281	CcSEcCtD
Acitretin—Vomiting—Dactinomycin—kidney cancer	0.000176	0.000281	CcSEcCtD
Acitretin—Somnolence—Paclitaxel—kidney cancer	0.000175	0.000278	CcSEcCtD
Acitretin—Rash—Dactinomycin—kidney cancer	0.000175	0.000278	CcSEcCtD
Acitretin—Nausea—Sunitinib—kidney cancer	0.000174	0.000277	CcSEcCtD
Acitretin—Pancytopenia—Doxorubicin—kidney cancer	0.000174	0.000277	CcSEcCtD
Acitretin—Dyspepsia—Paclitaxel—kidney cancer	0.000173	0.000276	CcSEcCtD
Acitretin—Cough—Capecitabine—kidney cancer	0.000173	0.000275	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—kidney cancer	0.000171	0.000272	CcSEcCtD
Acitretin—Decreased appetite—Paclitaxel—kidney cancer	0.000171	0.000272	CcSEcCtD
Acitretin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00017	0.00027	CcSEcCtD
Acitretin—Fatigue—Paclitaxel—kidney cancer	0.00017	0.00027	CcSEcCtD
Acitretin—Diarrhoea—Vincristine—kidney cancer	0.00017	0.00027	CcSEcCtD
Acitretin—Asthenia—Gemcitabine—kidney cancer	0.000169	0.000268	CcSEcCtD
Acitretin—Chest pain—Capecitabine—kidney cancer	0.000169	0.000268	CcSEcCtD
Acitretin—Arthralgia—Capecitabine—kidney cancer	0.000169	0.000268	CcSEcCtD
Acitretin—Myalgia—Capecitabine—kidney cancer	0.000169	0.000268	CcSEcCtD
Acitretin—Constipation—Paclitaxel—kidney cancer	0.000168	0.000268	CcSEcCtD
Acitretin—Pain—Paclitaxel—kidney cancer	0.000168	0.000268	CcSEcCtD
Acitretin—Anxiety—Capecitabine—kidney cancer	0.000168	0.000267	CcSEcCtD
Acitretin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000167	0.000266	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—kidney cancer	0.000167	0.000265	CcSEcCtD
Acitretin—Discomfort—Capecitabine—kidney cancer	0.000167	0.000265	CcSEcCtD
Acitretin—Pruritus—Gemcitabine—kidney cancer	0.000166	0.000265	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—kidney cancer	0.000166	0.000264	CcSEcCtD
Acitretin—Dry mouth—Capecitabine—kidney cancer	0.000165	0.000262	CcSEcCtD
Acitretin—Nausea—Dactinomycin—kidney cancer	0.000165	0.000262	CcSEcCtD
Acitretin—Dizziness—Vincristine—kidney cancer	0.000164	0.000261	CcSEcCtD
Acitretin—Feeling abnormal—Paclitaxel—kidney cancer	0.000162	0.000258	CcSEcCtD
Acitretin—Oedema—Capecitabine—kidney cancer	0.000162	0.000257	CcSEcCtD
Acitretin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000161	0.000256	CcSEcCtD
Acitretin—Diarrhoea—Gemcitabine—kidney cancer	0.000161	0.000256	CcSEcCtD
Acitretin—Infection—Capecitabine—kidney cancer	0.000161	0.000255	CcSEcCtD
Acitretin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.00016	0.000255	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—kidney cancer	0.000159	0.000253	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—kidney cancer	0.000159	0.000253	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—kidney cancer	0.000159	0.000252	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—kidney cancer	0.000159	0.000252	CcSEcCtD
Acitretin—Vomiting—Vincristine—kidney cancer	0.000158	0.000251	CcSEcCtD
Acitretin—Skin disorder—Capecitabine—kidney cancer	0.000157	0.00025	CcSEcCtD
Acitretin—Urticaria—Paclitaxel—kidney cancer	0.000156	0.000249	CcSEcCtD
Acitretin—Rash—Vincristine—kidney cancer	0.000156	0.000249	CcSEcCtD
Acitretin—Hyperhidrosis—Capecitabine—kidney cancer	0.000156	0.000248	CcSEcCtD
Acitretin—Dermatitis—Vincristine—kidney cancer	0.000156	0.000248	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—kidney cancer	0.000156	0.000248	CcSEcCtD
Acitretin—Abdominal pain—Paclitaxel—kidney cancer	0.000156	0.000248	CcSEcCtD
Acitretin—Body temperature increased—Paclitaxel—kidney cancer	0.000156	0.000248	CcSEcCtD
Acitretin—Headache—Vincristine—kidney cancer	0.000155	0.000247	CcSEcCtD
Acitretin—Epistaxis—Doxorubicin—kidney cancer	0.000154	0.000245	CcSEcCtD
Acitretin—Anorexia—Capecitabine—kidney cancer	0.000154	0.000245	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—kidney cancer	0.000153	0.000244	CcSEcCtD
Acitretin—Vomiting—Gemcitabine—kidney cancer	0.00015	0.000238	CcSEcCtD
Acitretin—Rash—Gemcitabine—kidney cancer	0.000148	0.000236	CcSEcCtD
Acitretin—Dermatitis—Gemcitabine—kidney cancer	0.000148	0.000236	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—kidney cancer	0.000147	0.000234	CcSEcCtD
Acitretin—Headache—Gemcitabine—kidney cancer	0.000147	0.000234	CcSEcCtD
Acitretin—Nausea—Vincristine—kidney cancer	0.000147	0.000234	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000147	0.000234	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—kidney cancer	0.000147	0.000234	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—kidney cancer	0.000147	0.000233	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—kidney cancer	0.000147	0.000233	CcSEcCtD
Acitretin—Insomnia—Capecitabine—kidney cancer	0.000146	0.000232	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—kidney cancer	0.000146	0.000232	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—kidney cancer	0.000146	0.000231	CcSEcCtD
Acitretin—Paraesthesia—Capecitabine—kidney cancer	0.000145	0.000231	CcSEcCtD
Acitretin—Hypersensitivity—Paclitaxel—kidney cancer	0.000145	0.000231	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—kidney cancer	0.000144	0.00023	CcSEcCtD
Acitretin—Dyspepsia—Capecitabine—kidney cancer	0.000142	0.000226	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—kidney cancer	0.000141	0.000225	CcSEcCtD
Acitretin—Asthenia—Paclitaxel—kidney cancer	0.000141	0.000225	CcSEcCtD
Acitretin—Decreased appetite—Capecitabine—kidney cancer	0.000141	0.000223	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—PAK1—kidney cancer	0.00014	0.000467	CbGpPWpGaD
Acitretin—Nausea—Gemcitabine—kidney cancer	0.00014	0.000222	CcSEcCtD
Acitretin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00014	0.000222	CcSEcCtD
Acitretin—RXRB—Gene Expression—PSMD7—kidney cancer	0.00014	0.000465	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PSMD7—kidney cancer	0.00014	0.000465	CbGpPWpGaD
Acitretin—Fatigue—Capecitabine—kidney cancer	0.000139	0.000222	CcSEcCtD
Acitretin—Pruritus—Paclitaxel—kidney cancer	0.000139	0.000222	CcSEcCtD
Acitretin—Constipation—Capecitabine—kidney cancer	0.000138	0.00022	CcSEcCtD
Acitretin—Pain—Capecitabine—kidney cancer	0.000138	0.00022	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000138	0.00046	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—SLC2A1—kidney cancer	0.000138	0.000459	CbGpPWpGaD
Acitretin—Eye disorder—Doxorubicin—kidney cancer	0.000137	0.000218	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—kidney cancer	0.000137	0.000217	CcSEcCtD
Acitretin—Flushing—Doxorubicin—kidney cancer	0.000136	0.000216	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000136	0.000452	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000136	0.000452	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—JUNB—kidney cancer	0.000136	0.000452	CbGpPWpGaD
Acitretin—Diarrhoea—Paclitaxel—kidney cancer	0.000135	0.000214	CcSEcCtD
Acitretin—RXRA—Gene Expression—EEF2—kidney cancer	0.000135	0.000448	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—JUNB—kidney cancer	0.000133	0.000444	CbGpPWpGaD
Acitretin—Feeling abnormal—Capecitabine—kidney cancer	0.000133	0.000212	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—kidney cancer	0.000133	0.000212	CcSEcCtD
Acitretin—RXRA—Metabolism—GLIPR1—kidney cancer	0.000132	0.000441	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPAT—kidney cancer	0.000132	0.000441	CbGpPWpGaD
Acitretin—Immune system disorder—Doxorubicin—kidney cancer	0.000132	0.000211	CcSEcCtD
Acitretin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000132	0.00021	CcSEcCtD
Acitretin—Chills—Doxorubicin—kidney cancer	0.000132	0.000209	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000131	0.000436	CbGpPWpGaD
Acitretin—RARB—Gene Expression—JUNB—kidney cancer	0.000131	0.000435	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—RELA—kidney cancer	0.000131	0.000435	CbGpPWpGaD
Acitretin—RBP1—Disease—HIF1A—kidney cancer	0.00013	0.000434	CbGpPWpGaD
Acitretin—Dizziness—Paclitaxel—kidney cancer	0.00013	0.000207	CcSEcCtD
Acitretin—RBP1—Disease—TSC2—kidney cancer	0.00013	0.000433	CbGpPWpGaD
Acitretin—Alopecia—Doxorubicin—kidney cancer	0.00013	0.000206	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000129	0.000431	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—TET2—kidney cancer	0.000129	0.00043	CbGpPWpGaD
Acitretin—Urticaria—Capecitabine—kidney cancer	0.000128	0.000204	CcSEcCtD
Acitretin—Abdominal pain—Capecitabine—kidney cancer	0.000128	0.000203	CcSEcCtD
Acitretin—Body temperature increased—Capecitabine—kidney cancer	0.000128	0.000203	CcSEcCtD
Acitretin—Erythema—Doxorubicin—kidney cancer	0.000128	0.000203	CcSEcCtD
Acitretin—RXRA—Developmental Biology—PAK1—kidney cancer	0.000128	0.000425	CbGpPWpGaD
Acitretin—Tension—Doxorubicin—kidney cancer	0.000125	0.000199	CcSEcCtD
Acitretin—RXRB—Gene Expression—JUNB—kidney cancer	0.000125	0.000417	CbGpPWpGaD
Acitretin—RARA—Gene Expression—JUNB—kidney cancer	0.000125	0.000417	CbGpPWpGaD
Acitretin—Vomiting—Paclitaxel—kidney cancer	0.000125	0.000199	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—kidney cancer	0.000125	0.000199	CcSEcCtD
Acitretin—Rash—Paclitaxel—kidney cancer	0.000124	0.000197	CcSEcCtD
Acitretin—Dermatitis—Paclitaxel—kidney cancer	0.000124	0.000197	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—kidney cancer	0.000124	0.000197	CcSEcCtD
Acitretin—Back pain—Doxorubicin—kidney cancer	0.000123	0.000196	CcSEcCtD
Acitretin—Headache—Paclitaxel—kidney cancer	0.000123	0.000196	CcSEcCtD
Acitretin—RXRA—Metabolism—APRT—kidney cancer	0.000123	0.00041	CbGpPWpGaD
Acitretin—RXRA—Metabolism—FH—kidney cancer	0.000123	0.00041	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000123	0.000409	CbGpPWpGaD
Acitretin—Muscle spasms—Doxorubicin—kidney cancer	0.000123	0.000195	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000122	0.000405	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.00012	0.000401	CbGpPWpGaD
Acitretin—Vision blurred—Doxorubicin—kidney cancer	0.00012	0.000191	CcSEcCtD
Acitretin—Hypersensitivity—Capecitabine—kidney cancer	0.000119	0.000189	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000119	0.000396	CbGpPWpGaD
Acitretin—RARG—Gene Expression—CDKN2B—kidney cancer	0.000119	0.000395	CbGpPWpGaD
Acitretin—Ill-defined disorder—Doxorubicin—kidney cancer	0.000118	0.000188	CcSEcCtD
Acitretin—RXRA—Gene Expression—TCEB1—kidney cancer	0.000118	0.000393	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—TCEB2—kidney cancer	0.000118	0.000393	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL2—kidney cancer	0.000118	0.000391	CbGpPWpGaD
Acitretin—Nausea—Paclitaxel—kidney cancer	0.000117	0.000186	CcSEcCtD
Acitretin—Asthenia—Capecitabine—kidney cancer	0.000116	0.000184	CcSEcCtD
Acitretin—RXRA—Metabolism—GPC3—kidney cancer	0.000116	0.000386	CbGpPWpGaD
Acitretin—Malaise—Doxorubicin—kidney cancer	0.000115	0.000183	CcSEcCtD
Acitretin—CYP26A1—Metabolism—GSTP1—kidney cancer	0.000115	0.000382	CbGpPWpGaD
Acitretin—RBP1—Disease—APC—kidney cancer	0.000115	0.000382	CbGpPWpGaD
Acitretin—RBP1—Disease—KIT—kidney cancer	0.000115	0.000382	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IGF2—kidney cancer	0.000115	0.000382	CbGpPWpGaD
Acitretin—Pruritus—Capecitabine—kidney cancer	0.000114	0.000182	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—CDKN2B—kidney cancer	0.000114	0.00038	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000113	0.000376	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ANXA2—kidney cancer	0.000113	0.000376	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CA2—kidney cancer	0.000113	0.000375	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000113	0.000375	CbGpPWpGaD
Acitretin—Cough—Doxorubicin—kidney cancer	0.000111	0.000177	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—IGF1R—kidney cancer	0.000111	0.000369	CbGpPWpGaD
Acitretin—Diarrhoea—Capecitabine—kidney cancer	0.000111	0.000176	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—CDKN2B—kidney cancer	0.00011	0.000368	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALAD—kidney cancer	0.00011	0.000366	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000109	0.000364	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ABCB1—kidney cancer	0.000109	0.000362	CbGpPWpGaD
Acitretin—Chest pain—Doxorubicin—kidney cancer	0.000109	0.000173	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—kidney cancer	0.000109	0.000173	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—kidney cancer	0.000109	0.000173	CcSEcCtD
Acitretin—RXRG—Gene Expression—CDKN2B—kidney cancer	0.000108	0.000361	CbGpPWpGaD
Acitretin—Anxiety—Doxorubicin—kidney cancer	0.000108	0.000172	CcSEcCtD
Acitretin—RBP1—Disease—BRAF—kidney cancer	0.000108	0.000359	CbGpPWpGaD
Acitretin—Discomfort—Doxorubicin—kidney cancer	0.000107	0.000171	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000107	0.000357	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ST3GAL2—kidney cancer	0.000107	0.000357	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000107	0.000357	CbGpPWpGaD
Acitretin—Dizziness—Capecitabine—kidney cancer	0.000107	0.00017	CcSEcCtD
Acitretin—RARB—Gene Expression—CDKN2B—kidney cancer	0.000106	0.000354	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000106	0.000354	CbGpPWpGaD
Acitretin—Dry mouth—Doxorubicin—kidney cancer	0.000106	0.000169	CcSEcCtD
Acitretin—CYP26A1—Metabolism—GSTM1—kidney cancer	0.000106	0.000351	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALDH1A1—kidney cancer	0.000105	0.000349	CbGpPWpGaD
Acitretin—Oedema—Doxorubicin—kidney cancer	0.000104	0.000166	CcSEcCtD
Acitretin—ALB—Selenium Micronutrient Network—RELA—kidney cancer	0.000104	0.000345	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000104	0.000345	CbGpPWpGaD
Acitretin—Infection—Doxorubicin—kidney cancer	0.000104	0.000165	CcSEcCtD
Acitretin—Vomiting—Capecitabine—kidney cancer	0.000103	0.000163	CcSEcCtD
Acitretin—RXRB—Gene Expression—CDKN2B—kidney cancer	0.000102	0.00034	CbGpPWpGaD
Acitretin—RARA—Gene Expression—CDKN2B—kidney cancer	0.000102	0.00034	CbGpPWpGaD
Acitretin—Rash—Capecitabine—kidney cancer	0.000102	0.000162	CcSEcCtD
Acitretin—Dermatitis—Capecitabine—kidney cancer	0.000102	0.000162	CcSEcCtD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000101	0.000338	CbGpPWpGaD
Acitretin—Headache—Capecitabine—kidney cancer	0.000101	0.000161	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—kidney cancer	0.000101	0.000161	CcSEcCtD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	0.000101	0.000335	CbGpPWpGaD
Acitretin—Hyperhidrosis—Doxorubicin—kidney cancer	0.000101	0.00016	CcSEcCtD
Acitretin—RXRA—Metabolism—SLC5A3—kidney cancer	0.0001	0.000334	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PGK1—kidney cancer	0.0001	0.000334	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CYP1A1—kidney cancer	0.0001	0.000333	CbGpPWpGaD
Acitretin—Anorexia—Doxorubicin—kidney cancer	9.93e-05	0.000158	CcSEcCtD
Acitretin—RXRA—Metabolism—LDHB—kidney cancer	9.85e-05	0.000328	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	9.8e-05	0.000326	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	9.78e-05	0.000326	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	9.78e-05	0.000326	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	9.78e-05	0.000326	CbGpPWpGaD
Acitretin—Nausea—Capecitabine—kidney cancer	9.6e-05	0.000153	CcSEcCtD
Acitretin—RXRA—Gene Expression—RPL14—kidney cancer	9.6e-05	0.00032	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—MYC—kidney cancer	9.55e-05	0.000318	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.49e-05	0.000151	CcSEcCtD
Acitretin—Insomnia—Doxorubicin—kidney cancer	9.42e-05	0.00015	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	9.36e-05	0.000312	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KCNMA1—kidney cancer	9.36e-05	0.000312	CbGpPWpGaD
Acitretin—Paraesthesia—Doxorubicin—kidney cancer	9.36e-05	0.000149	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—kidney cancer	9.26e-05	0.000147	CcSEcCtD
Acitretin—Dyspepsia—Doxorubicin—kidney cancer	9.17e-05	0.000146	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—HIF1A—kidney cancer	9.13e-05	0.000304	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TSC2—kidney cancer	9.1e-05	0.000303	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	9.06e-05	0.000302	CbGpPWpGaD
Acitretin—Decreased appetite—Doxorubicin—kidney cancer	9.06e-05	0.000144	CcSEcCtD
Acitretin—RBP1—Disease—RAF1—kidney cancer	9.01e-05	0.0003	CbGpPWpGaD
Acitretin—Gastrointestinal disorder—Doxorubicin—kidney cancer	9e-05	0.000143	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—kidney cancer	8.98e-05	0.000143	CcSEcCtD
Acitretin—RBP1—Disease—ERBB2—kidney cancer	8.91e-05	0.000297	CbGpPWpGaD
Acitretin—Constipation—Doxorubicin—kidney cancer	8.91e-05	0.000142	CcSEcCtD
Acitretin—Pain—Doxorubicin—kidney cancer	8.91e-05	0.000142	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	8.85e-05	0.000295	CbGpPWpGaD
Acitretin—RBP1—Disease—MTOR—kidney cancer	8.8e-05	0.000293	CbGpPWpGaD
Acitretin—RBP1—Disease—CD4—kidney cancer	8.78e-05	0.000292	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—MYC—kidney cancer	8.73e-05	0.000291	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KDR—kidney cancer	8.73e-05	0.000291	CbGpPWpGaD
Acitretin—ALB—Metabolism—ACY1—kidney cancer	8.72e-05	0.00029	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—kidney cancer	8.72e-05	0.00029	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.62e-05	0.000287	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	8.61e-05	0.000287	CbGpPWpGaD
Acitretin—Feeling abnormal—Doxorubicin—kidney cancer	8.59e-05	0.000136	CcSEcCtD
Acitretin—ALB—Platelet degranulation—VEGFA—kidney cancer	8.56e-05	0.000285	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MYC—kidney cancer	8.56e-05	0.000285	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CA9—kidney cancer	8.54e-05	0.000284	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Doxorubicin—kidney cancer	8.52e-05	0.000135	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	8.43e-05	0.000281	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.34e-05	0.000278	CbGpPWpGaD
Acitretin—Urticaria—Doxorubicin—kidney cancer	8.28e-05	0.000132	CcSEcCtD
Acitretin—RBP1—Disease—CDKN1B—kidney cancer	8.26e-05	0.000275	CbGpPWpGaD
Acitretin—Abdominal pain—Doxorubicin—kidney cancer	8.24e-05	0.000131	CcSEcCtD
Acitretin—Body temperature increased—Doxorubicin—kidney cancer	8.24e-05	0.000131	CcSEcCtD
Acitretin—RXRB—Generic Transcription Pathway—MYC—kidney cancer	8.21e-05	0.000273	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MYC—kidney cancer	8.21e-05	0.000273	CbGpPWpGaD
Acitretin—ALB—Hemostasis—GRB7—kidney cancer	8.17e-05	0.000272	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	8.16e-05	0.000272	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KIT—kidney cancer	8.04e-05	0.000268	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—APC—kidney cancer	8.04e-05	0.000268	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.96e-05	0.000265	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KDR—kidney cancer	7.94e-05	0.000265	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—HSPB1—kidney cancer	7.82e-05	0.00026	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—EIF4EBP1—kidney cancer	7.82e-05	0.00026	CbGpPWpGaD
Acitretin—RBP1—Disease—CTNNB1—kidney cancer	7.8e-05	0.00026	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MET—kidney cancer	7.77e-05	0.000259	CbGpPWpGaD
Acitretin—Hypersensitivity—Doxorubicin—kidney cancer	7.68e-05	0.000122	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—POMC—kidney cancer	7.65e-05	0.000255	CbGpPWpGaD
Acitretin—RBP1—Disease—PTEN—kidney cancer	7.6e-05	0.000253	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ITPR2—kidney cancer	7.59e-05	0.000253	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—BRAF—kidney cancer	7.56e-05	0.000252	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—kidney cancer	7.55e-05	0.000251	CbGpPWpGaD
Acitretin—Asthenia—Doxorubicin—kidney cancer	7.48e-05	0.000119	CcSEcCtD
Acitretin—CYP26A1—Metabolism—POMC—kidney cancer	7.46e-05	0.000248	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	7.43e-05	0.000248	CbGpPWpGaD
Acitretin—ALB—Metabolism—PDHB—kidney cancer	7.41e-05	0.000247	CbGpPWpGaD
Acitretin—Pruritus—Doxorubicin—kidney cancer	7.37e-05	0.000117	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.31e-05	0.000243	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PSMD7—kidney cancer	7.27e-05	0.000242	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CRABP1—kidney cancer	7.26e-05	0.000242	CbGpPWpGaD
Acitretin—Diarrhoea—Doxorubicin—kidney cancer	7.13e-05	0.000113	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	7.07e-05	0.000235	CbGpPWpGaD
Acitretin—ALB—Metabolism—CCBL1—kidney cancer	6.97e-05	0.000232	CbGpPWpGaD
Acitretin—Dizziness—Doxorubicin—kidney cancer	6.89e-05	0.00011	CcSEcCtD
Acitretin—RXRA—Metabolism—ITPR2—kidney cancer	6.75e-05	0.000225	CbGpPWpGaD
Acitretin—Vomiting—Doxorubicin—kidney cancer	6.63e-05	0.000105	CcSEcCtD
Acitretin—Rash—Doxorubicin—kidney cancer	6.57e-05	0.000104	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—kidney cancer	6.56e-05	0.000104	CcSEcCtD
Acitretin—RXRA—Gene Expression—JUNB—kidney cancer	6.53e-05	0.000217	CbGpPWpGaD
Acitretin—Headache—Doxorubicin—kidney cancer	6.53e-05	0.000104	CcSEcCtD
Acitretin—RBP1—Disease—MAPK3—kidney cancer	6.5e-05	0.000216	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—kidney cancer	6.32e-05	0.00021	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RAF1—kidney cancer	6.31e-05	0.00021	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.3e-05	0.00021	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RELA—kidney cancer	6.28e-05	0.000209	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ERBB2—kidney cancer	6.24e-05	0.000208	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.22e-05	0.000207	CbGpPWpGaD
Acitretin—Nausea—Doxorubicin—kidney cancer	6.19e-05	9.84e-05	CcSEcCtD
Acitretin—RBP1—Disease—MAPK1—kidney cancer	6.18e-05	0.000206	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MTOR—kidney cancer	6.16e-05	0.000205	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ACHE—kidney cancer	6.15e-05	0.000205	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTT1—kidney cancer	6.15e-05	0.000205	CbGpPWpGaD
Acitretin—ALB—Metabolism—GLIPR1—kidney cancer	6.04e-05	0.000201	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPAT—kidney cancer	6.04e-05	0.000201	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.97e-05	0.000199	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—kidney cancer	5.95e-05	0.000198	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.91e-05	0.000197	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—kidney cancer	5.84e-05	0.000194	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SCARB1—kidney cancer	5.83e-05	0.000194	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1B—kidney cancer	5.78e-05	0.000192	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS1—kidney cancer	5.77e-05	0.000192	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—RAF1—kidney cancer	5.74e-05	0.000191	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—RELA—kidney cancer	5.72e-05	0.00019	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—kidney cancer	5.68e-05	0.000189	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—kidney cancer	5.66e-05	0.000188	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PSMD7—kidney cancer	5.66e-05	0.000188	CbGpPWpGaD
Acitretin—ALB—Metabolism—APRT—kidney cancer	5.62e-05	0.000187	CbGpPWpGaD
Acitretin—ALB—Metabolism—FH—kidney cancer	5.62e-05	0.000187	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA1—kidney cancer	5.57e-05	0.000186	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—kidney cancer	5.52e-05	0.000184	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—JUN—kidney cancer	5.5e-05	0.000183	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.49e-05	0.000183	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—kidney cancer	5.46e-05	0.000182	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—kidney cancer	5.36e-05	0.000179	CbGpPWpGaD
Acitretin—RXRA—Metabolism—BCHE—kidney cancer	5.36e-05	0.000178	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—kidney cancer	5.32e-05	0.000177	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CDKN2B—kidney cancer	5.31e-05	0.000177	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC5A5—kidney cancer	5.3e-05	0.000176	CbGpPWpGaD
Acitretin—ALB—Metabolism—GPC3—kidney cancer	5.28e-05	0.000176	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—kidney cancer	5.19e-05	0.000173	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA2—kidney cancer	5.19e-05	0.000173	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.16e-05	0.000172	CbGpPWpGaD
Acitretin—ALB—Metabolism—CA2—kidney cancer	5.14e-05	0.000171	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC2A1—kidney cancer	5.11e-05	0.00017	CbGpPWpGaD
Acitretin—ALB—Metabolism—ALAD—kidney cancer	5.01e-05	0.000167	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	4.99e-05	0.000166	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.98e-05	0.000166	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—kidney cancer	4.97e-05	0.000166	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.96e-05	0.000165	CbGpPWpGaD
Acitretin—ALB—Metabolism—ST3GAL2—kidney cancer	4.89e-05	0.000163	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—RAF1—kidney cancer	4.88e-05	0.000162	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—kidney cancer	4.81e-05	0.00016	CbGpPWpGaD
Acitretin—ALB—Metabolism—ALDH1A1—kidney cancer	4.78e-05	0.000159	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MAPK3—kidney cancer	4.73e-05	0.000157	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IGF2—kidney cancer	4.67e-05	0.000155	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—kidney cancer	4.6e-05	0.000153	CbGpPWpGaD
Acitretin—ALB—Metabolism—PGK1—kidney cancer	4.58e-05	0.000152	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC5A3—kidney cancer	4.58e-05	0.000152	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK3—kidney cancer	4.55e-05	0.000151	CbGpPWpGaD
Acitretin—ALB—Metabolism—LDHB—kidney cancer	4.49e-05	0.00015	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	4.47e-05	0.000149	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—kidney cancer	4.42e-05	0.000147	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—kidney cancer	4.38e-05	0.000146	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK1—kidney cancer	4.33e-05	0.000144	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.33e-05	0.000144	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MAPK3—kidney cancer	4.32e-05	0.000144	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—kidney cancer	4.28e-05	0.000142	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTP1—kidney cancer	4.27e-05	0.000142	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MAPK3—kidney cancer	4.24e-05	0.000141	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—kidney cancer	4.2e-05	0.00014	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK3—kidney cancer	4.14e-05	0.000138	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—kidney cancer	4.12e-05	0.000137	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—kidney cancer	4.09e-05	0.000136	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MAPK3—kidney cancer	4.06e-05	0.000135	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MAPK3—kidney cancer	4.06e-05	0.000135	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ABCB1—kidney cancer	4.04e-05	0.000134	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—kidney cancer	3.95e-05	0.000132	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—kidney cancer	3.95e-05	0.000132	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK1—kidney cancer	3.94e-05	0.000131	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.93e-05	0.000131	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTM1—kidney cancer	3.92e-05	0.000131	CbGpPWpGaD
Acitretin—ALB—Metabolism—CA9—kidney cancer	3.89e-05	0.00013	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.81e-05	0.000127	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	3.8e-05	0.000126	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—kidney cancer	3.76e-05	0.000125	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—kidney cancer	3.72e-05	0.000124	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP1A1—kidney cancer	3.72e-05	0.000124	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—kidney cancer	3.66e-05	0.000122	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—kidney cancer	3.63e-05	0.000121	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	3.59e-05	0.00012	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	3.42e-05	0.000114	CbGpPWpGaD
Acitretin—ALB—Metabolism—CRABP1—kidney cancer	3.31e-05	0.00011	CbGpPWpGaD
Acitretin—ALB—Metabolism—ITPR2—kidney cancer	3.08e-05	0.000102	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.05e-05	0.000102	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2.97e-05	9.88e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.84e-05	9.45e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ACHE—kidney cancer	2.81e-05	9.35e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTT1—kidney cancer	2.81e-05	9.35e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—POMC—kidney cancer	2.77e-05	9.22e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SCARB1—kidney cancer	2.66e-05	8.85e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS1—kidney cancer	2.63e-05	8.76e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PSMD7—kidney cancer	2.58e-05	8.59e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—RAF1—kidney cancer	2.57e-05	8.56e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—BCHE—kidney cancer	2.45e-05	8.14e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC5A5—kidney cancer	2.42e-05	8.04e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC2A1—kidney cancer	2.33e-05	7.77e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—kidney cancer	2.3e-05	7.67e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.26e-05	7.54e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	2.22e-05	7.41e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—kidney cancer	2.21e-05	7.36e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MAPK3—kidney cancer	2.12e-05	7.05e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—kidney cancer	2.06e-05	6.86e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.97e-05	6.57e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—kidney cancer	1.96e-05	6.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTP1—kidney cancer	1.95e-05	6.48e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—kidney cancer	1.93e-05	6.42e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK3—kidney cancer	1.85e-05	6.17e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCB1—kidney cancer	1.84e-05	6.13e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTM1—kidney cancer	1.79e-05	5.95e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK1—kidney cancer	1.76e-05	5.87e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP1A1—kidney cancer	1.69e-05	5.64e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—kidney cancer	1.66e-05	5.54e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—kidney cancer	1.53e-05	5.09e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—kidney cancer	1.48e-05	4.93e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.39e-05	4.64e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—kidney cancer	1.36e-05	4.53e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—POMC—kidney cancer	1.26e-05	4.21e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—kidney cancer	1.01e-05	3.36e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—kidney cancer	8.79e-06	2.93e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—kidney cancer	6.2e-06	2.06e-05	CbGpPWpGaD
